The stock is in a pronounced and sustained downtrend, having declined 49.94% over the past year. With a current price of $112.5, it is trading just above its 52-week low of $110.36, positioning it at a mere 1.3% of its 52-week range ($276.0 high to $110.36 low). This positioning near the absolute lows suggests the stock is deeply oversold, but also indicates a complete breakdown of support and a potential 'falling knife' scenario where further declines are possible. Short-term momentum is severely negative and accelerating the longer-term downtrend, with the stock down 45.70% over the past three months and 18.38% in the last month alone. This acceleration of selling pressure is confirmed by a massive underperformance relative to the S&P 500 (SPY), which is up 29.52% over the past year, resulting in a staggering -79.46% relative strength reading for WDAY. Key technical levels are clearly defined, with immediate support at the 52-week low of $110.36 and major resistance far above at the 52-week high of $276.0. A breakdown below $110.36 could trigger another leg down, while any recovery would face a long climb through multiple resistance zones. The stock's beta of 1.141 indicates it is approximately 14% more volatile than the broader market, which has amplified losses during this downturn and is a critical factor for risk management.

Revenue growth remains positive but has shown signs of deceleration. The most recent quarterly revenue (Q4 FY26 ending Jan 31, 2026) was $2.532 billion, representing a 14.52% year-over-year increase. However, examining the sequential quarterly revenue from the income statements shows a trend: $2.24B (Q1), $2.348B (Q2), $2.432B (Q3), to $2.532B (Q4). While still growing, the pace from Q3 to Q4 (+4.1% quarter-over-quarter) is slower than from Q2 to Q3 (+3.6% q/q), indicating potential moderation in growth momentum. The company is profitable, with net income of $145 million in the latest quarter and a trailing twelve-month free cash flow of $2.777 billion. Profitability margins are healthy but have shown some quarterly volatility; the latest gross margin was 75.87%, while the operating margin was 12.01%. It is notable that net income of $145M in Q4 was significantly lower than the $252M reported in Q3, suggesting potential margin pressure or one-time items impacting the bottom line. The balance sheet and cash flow position remain strong, underpinning financial health. The company has a moderate debt-to-equity ratio of 0.49 and a solid current ratio of 1.32, indicating sufficient liquidity. Most importantly, the robust free cash flow generation of $2.777 billion TTM provides ample internal funding for operations, investments, and the significant stock repurchase activity evidenced in the cash flow statements (e.g., $1.504 billion in repurchases in Q4 FY26).